These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11682606)

  • 1. CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes.
    Wallach-Dayan SB; Grabovsky V; Moll J; Sleeman J; Herrlich P; Alon R; Naor D
    J Cell Sci; 2001 Oct; 114(Pt 19):3463-77. PubMed ID: 11682606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs.
    Vogt Sionov R; Naor D
    Int J Cancer; 1997 May; 71(3):462-9. PubMed ID: 9139885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
    Zahalka MA; Okon E; Gosslar U; Holzmann B; Naor D
    J Immunol; 1995 May; 154(10):5345-55. PubMed ID: 7537306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.
    Naor D; Wallach-Dayan SB; Zahalka MA; Sionov RV
    Semin Cancer Biol; 2008 Aug; 18(4):260-7. PubMed ID: 18467123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD44 receptor of lymphoma cells: structure-function relationships and mechanism of activation.
    Rochman M; Moll J; Herrlich P; Wallach SB; Nedvetzki S; Sionov RV; Golan I; Ish-Shalom D; Naor D
    Cell Adhes Commun; 2000 Jan; 7(4):331-47. PubMed ID: 10714394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
    Wallach SB; Friedmann A; Naor D
    Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma.
    Clark RA; Alon R; Springer TA
    J Cell Biol; 1996 Aug; 134(4):1075-87. PubMed ID: 8769428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 2-integrin dependent aggregate formation between LB T cell lymphoma and spleen cells: assessment of correlation with spleen invasiveness.
    Zahalka MA; Naor D
    Int Immunol; 1994 Jun; 6(6):917-24. PubMed ID: 7522049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
    Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
    J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.
    Bourguignon LY; Zhu H; Shao L; Chen YW
    J Biol Chem; 2000 Jan; 275(3):1829-38. PubMed ID: 10636882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the extracellular and cytoplasmic domains of CD44 in the rolling interaction of lymphoid cells with hyaluronan under physiologic flow.
    Gal I; Lesley J; Ko W; Gonda A; Stoop R; Hyman R; Mikecz K
    J Biol Chem; 2003 Mar; 278(13):11150-8. PubMed ID: 12540844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of CD44 with different forms of hyaluronic acid. Its role in adhesion and migration of tumor cells.
    Alaniz L; Cabrera PV; Blanco G; Ernst G; Rimoldi G; Alvarez E; Hajos SE
    Cell Commun Adhes; 2002; 9(3):117-30. PubMed ID: 12521133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
    Harada N; Mizoi T; Kinouchi M; Hoshi K; Ishii S; Shiiba K; Sasaki I; Matsuno S
    Int J Cancer; 2001 Jan; 91(1):67-75. PubMed ID: 11149422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration.
    Bourguignon LY; Zhu H; Shao L; Chen YW
    J Biol Chem; 2001 Mar; 276(10):7327-36. PubMed ID: 11084024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis.
    Iida N; Bourguignon LY
    J Cell Physiol; 1997 May; 171(2):152-60. PubMed ID: 9130462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
    Sleeman J; Rudy W; Hofmann M; Moll J; Herrlich P; Ponta H
    J Cell Biol; 1996 Nov; 135(4):1139-50. PubMed ID: 8922392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
    Fang XJ; Jiang H; Zhao XP; Jiang WM
    BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 mediates the catch-bond activated rolling of HEPG2Iso epithelial cancer cells on hyaluronan.
    Hanke-Roos M; Fuchs K; Maleschlijski S; Sleeman J; Orian-Rousseau V; Rosenhahn A
    Cell Adh Migr; 2017 Sep; 11(5-6):476-487. PubMed ID: 27874296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for CD44 in activated T cell extravasation into an inflammatory site.
    DeGrendele HC; Estess P; Siegelman MH
    Science; 1997 Oct; 278(5338):672-5. PubMed ID: 9381175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.